DON’T WASTE A CRISIS. REGULATORY FLEXIBILITY MERITS SERIOUS CONSIDERATION FOR THE LONG TERM. by Dvorah A. Richman, ©2020 (Jul. 1, 2020) — The press has obsessively focused on supposed government shortfalls regarding COVID-19 testing. However, virtually no attention has been given to the Food and Drug Administration’s (FDA’s) vigorous and unprecedented efforts to ease regulatory […]
Tag: medical devices
Posted inEditorials